↓ Skip to main content

Dove Medical Press

Article Metrics

Optimal management of ADHD in older adults

Overview of attention for article published in Neuropsychiatric Disease and Treatment, January 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

blogs
2 blogs
twitter
19 tweeters
facebook
3 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
87 Mendeley
Title
Optimal management of ADHD in older adults
Published in
Neuropsychiatric Disease and Treatment, January 2016
DOI 10.2147/ndt.s59271
Pubmed ID
Authors

Terje Torgersen, Bjørn Gjervan, Michael B. Lensing, Kirsten Rasmussen

Abstract

The manifestation of attention-deficit/hyperactivity disorder (ADHD) among older adults has become an interesting topic of interest due to an increasing number of adults aged 50 years and older (≥50 years) seeking assessment for ADHD. Unfortunately, there is a lack of research on ADHD in older adults, and until recently only a few case reports existed. A systematic search was conducted in the databases Medline/PubMed and PsycINFO in order to identify studies regarding ADHD in adults ≥50 years. ADHD persists into older ages in many patients, but the prevalence of patients fulfilling the criteria for the diagnosis at age ≥50 years is still unknown. It is reason to believe that the prevalence is falling gradually with age, and that the ADHD symptom level is significantly lower in the age group 70-80 years than the group 50-60 years. There is a lack of controlled studies of ADHD medication in adults ≥50 years, but this review suggests that many patients aged ≥50 years experience beneficial effects of pharmacological treatment. The problem with side effects and somatic complications may rise to a level that makes pharmacotherapy for ADHD difficult after the age of 65 years. Physical assessment prior to initiation of ADHD medication in adults ≥50 years should include a thorough clinical examination, and medication should be titrated with low doses initially and with a slow increase. In motivated patients, different psychological therapies alone or in addition to pharmacotherapy should be considered. It is essential when treating older adult patients with ADHD to provide good support based on knowledge and understanding of how ADHD symptoms have affected health, quality of life, and function through the life span. Individualized therapy for each elderly patient should be recommended to balance risk-benefit ratio when pharmacotherapy is considered to be a possible treatment.

Twitter Demographics

The data shown below were collected from the profiles of 19 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Canada 1 1%
Australia 1 1%
Unknown 84 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 16%
Student > Master 12 14%
Other 10 11%
Student > Doctoral Student 8 9%
Student > Bachelor 7 8%
Other 22 25%
Unknown 14 16%
Readers by discipline Count As %
Medicine and Dentistry 25 29%
Psychology 21 24%
Neuroscience 6 7%
Nursing and Health Professions 5 6%
Social Sciences 4 5%
Other 8 9%
Unknown 18 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2020.
All research outputs
#620,010
of 15,284,323 outputs
Outputs from Neuropsychiatric Disease and Treatment
#75
of 2,510 outputs
Outputs of similar age
#18,282
of 369,412 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 67 outputs
Altmetric has tracked 15,284,323 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,510 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,412 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.